The global inhalable drugs market is witnessing strong momentum as respiratory diseases, innovative drug delivery technologies, and patient preference for non-invasive therapies continue to reshape pharmaceutical development. According to industry analysis, Global Inhalable Drugs Market is expected to grow from US$ 8.12 billion in 2025 to US$ 16.88 billion by 2034, registering a CAGR of 8.47%...